Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 13/20 | 0.53 |
| ▸ | ADORA1 | P30542 | 15/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 11/20 | 0.47 |
| ▸ | VCP | P55072 | 1/20 | 0.46 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7227674 | 0.89 | ADORA3 (0.58) | ADORA3ADORA1ADORA2AVCPADORA2B | |
| SCHEMBL7229917 | 0.81 | ADORA3 (0.58) | ADORA3ADORA1ADORA2AVCPADORA2B | |
| SCHEMBL7228648 | 0.80 | KCNH2 (0.42) | ADORA3KCNH2MEN1ALDH1A1POLB | |
| SCHEMBL21953109 | 0.75 | ADORA3 (0.49) | ADORA3VCPALDH1A1 | |
| SCHEMBL7501309 | 0.72 | ADORA1 (0.57) | ADORA3ADORA1ADORA2AADORA2BMEN1 | |
| SCHEMBL8438011 | 0.72 | PTGS2 (0.50) | ALDH1A1KMT2A | |
| SCHEMBL7502465 | 0.69 | PTGS2 (0.49) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL7228763 | 0.68 | DPP4 (0.44) | ADORA3MEN1KMT2A | |
| SCHEMBL7507216 | 0.67 | PDE4B (0.46) | MEN1ALDH1A1POLBKMT2A | |
| SCHEMBL7500578 | 0.67 | KMT2A (0.51) | ADORA3ADORA1ADORA2AADORA2BKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6620817-B1 | Antiinflammatory, antiarthritic agents; autoimmune and rheumatic diseases | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 2003-09-16 | — | — | US | disclosed |
| EP-1236721-A1 | 5-CHLORO-6-PHENYL-2-(4-TRIFLUOROMETHYLPHENYL)-4-PYRIMIDINYLAMINO]ACETAMIDE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, MEDICINAL COMPOSITIONS CONTAINING THE SAME AND INTERMEDIATE OF THESE COMPOUNDS | Dainippon Pharmaceutical Co., Ltd. (JP) | 2002-09-04 | — | — | EP | disclosed |